Realising opportunities for future growth and financial update: Sobi Capital Markets Day 2020
Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI ) is hosting a virtual Capital Markets Day today. Presentations from senior management will showcase Sobi’s strategy for growth in the core areas of Immunology and Haematology, strengthening its pipeline, extending its geographical footprint and expanding growth opportunities. New peak sales expectations for key products as well as revenue ambition for 2025 are communicated. “Sobi has been through a significant transformation in the past few years and we are now well positioned for the next phase,” says Guido